Arlington, VA, United States of America

Jin Pei

This inventor holds 1 USPTO granted patent. Top assignees: Georgetown University, Neopharm, Inc.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jin Pei. Retrieved from https://idiyas.com/inventor/jin-pei-k1o60aje

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jin Pei: Innovator in Chemotherapy Enhancement

Introduction

Jin Pei is an accomplished inventor based in Arlington, VA (US). He has made significant contributions to the field of cancer treatment through his innovative work in enhancing the efficacy of chemotherapy and radiotherapy.

Latest Patents

Jin Pei holds a patent for "Chemosensitizing with liposomes containing oligonucleotides." This invention relates to the use of oligonucleotide-containing cationic liposomal formulations to enhance the effectiveness of chemotherapy and/or radiotherapy. It is particularly beneficial for sensitizing cancerous tumor tissues, especially in treating raf-expressing tumors such as breast, lung, pancreatic, and prostate tumors. He has 1 patent to his name.

Career Highlights

Throughout his career, Jin Pei has worked with notable institutions, including Georgetown University and Neopharm, Inc. His work has focused on developing innovative solutions to improve cancer treatment outcomes.

Collaborations

Jin Pei has collaborated with esteemed colleagues such as Usha Kasid and Prafulla Gokhale. Their combined expertise has contributed to advancements in cancer research and treatment methodologies.

Conclusion

Jin Pei's innovative contributions to cancer treatment through his patented work exemplify the impact of research and collaboration in the medical field. His dedication to enhancing chemotherapy efficacy continues to inspire advancements in cancer therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…